We’ve compiled a list of product recalls issued by the US Food and Drug Administration (FDA) from this past week.
Kakah Life Issues Recall for Kratom Because of Possible Salmonella Contamination
Zakah Life, LLC of Ankeny, Iowa, is recalling the following Kratom products (Super Green Maeng Da Premium Kratom powder, Powerful Red Vein Bali Premium Kratom powder, Super Green Maeng Da Premium Kratom capsules, and Powerful Red Vein Bali Premium Kratom capsules) with expiration dates prior to 01/01/2023 because they have the potential of being contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
No illnesses have been reported to date in connection with this problem.
The potential for contamination was noted after laboratory testing revealed the presence of Salmonella in some packages of Super Green Maeng Da Kratom powder, Red Powder Vein Bali Kratom powder, Super Green Maeng Da Premium Kratom capsules, and Powerful Red Vein Bali Premium Kratom capsules.
Production of the product has been suspended while the FDA and the company continue their investigation as to the source of the problem.
For more information about this kratom recall, consult the official announcement.
World Organix Recalls Kratom Products Contaminated with High Microbial Loads
World Organix LLC, is voluntarily recalling lot: 112710 of Blissful Remedies Red Maeng Da 100% Mitragyna Speciosa capsules, Blissful Remedies Red Maeng Da Liquid Kratom Mitragyna Speciosa, Blissful Remedies 4 Hour Chill Slow Motion Blend to the consumer level. These products have been tested by the U.S. Food and Drug Administration (“FDA”) and found to be contaminated with High Microbial Loads.
These are unapproved products. The Maeng Da products, containing M. speciose, has psychoactive properties. The 4 Hour Chill Herbal Shot, contains melatonin, which has been reported to treat insomnia.
To learn more about this kratom product recall, read the recall statement.
Westminster Pharmaceuticals Recalls Levothyroxine and Liothyronine Due to Risk of Adulteration
Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg to the wholesale level. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduced into the manufacturing process.
For a list of products affected by this recall, check out the recall notice.